Journal of Asthma
Volume 58, 2021 - Issue 8
Commentary
Position statement: asthma in Latin America. IS short-acting beta-2 agonist helping or compromising asthma management?
L. J. Nanninia Hospital de G. Baigorria, Universidad Nacional Rosario, Santa Fe, ArgentinaCorrespondence[email protected]
https://orcid.org/0000-0002-9868-9883
, MDhttps://orcid.org/0000-0002-9868-9883, , MD, , MD, J. M. Antunezd Clínica Alemana, Vitacura, Chilehttps://orcid.org/0000-0002-5759-0377
, MDhttps://orcid.org/0000-0002-5759-0377, J. L. Miguel Reyese Instituto Nacional de Enfermedades Respiratorias, Ciudad de México, Mexicohttps://orcid.org/0000-0002-4071-3254
, MDhttps://orcid.org/0000-0002-4071-3254, , MD & R. Stelmachf Pulmonary Division–Heart Institute (InCor), Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazilhttps://orcid.org/0000-0002-5132-1934
, MDhttps://orcid.org/0000-0002-5132-1934 show all